Guizhou Sanli PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Guizhou Sanli PharmaceuticalLtd has a total shareholder equity of CN¥1.8B and total debt of CN¥509.5M, which brings its debt-to-equity ratio to 28.4%. Its total assets and total liabilities are CN¥2.9B and CN¥1.2B respectively. Guizhou Sanli PharmaceuticalLtd's EBIT is CN¥278.7M making its interest coverage ratio -5.5. It has cash and short-term investments of CN¥630.0M.
Key information
28.4%
Debt to equity ratio
CN¥509.47m
Debt
| Interest coverage ratio | -5.5x |
| Cash | CN¥629.96m |
| Equity | CN¥1.79b |
| Total liabilities | CN¥1.16b |
| Total assets | CN¥2.95b |
Recent financial health updates
Recent updates
Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 23
Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly
Mar 25Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 06Financial Position Analysis
Short Term Liabilities: 603439's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥783.7M).
Long Term Liabilities: 603439's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥371.8M).
Debt to Equity History and Analysis
Debt Level: 603439 has more cash than its total debt.
Reducing Debt: 603439's debt to equity ratio has increased from 0% to 28.4% over the past 5 years.
Debt Coverage: 603439's debt is well covered by operating cash flow (55.8%).
Interest Coverage: 603439 earns more interest than it pays, so coverage of interest payments is not a concern.